Try our Advanced Search for more refined results

In Re: Prempro Products et al

Track this case

Case overview

Case Number:

4:03-cv-01507

Court:

Arkansas Eastern

Nature of Suit:

Personal Inj. Prod. Liability

Judge:

Billy Roy Wilson

Firms

Companies

Sectors & Industries:

  1. June 19, 2012

    Pfizer Storing Up $330M To Settle Menopause Drug Suits

    Pfizer Inc. has set aside $330 million to settle multidistrict litigation and other remaining claims over injuries allegedly caused by hormone replacement therapies such as Prempro, a sum that would bring the drugmaker's total litigation losses to $1.2 billion, according to a regulatory filing last month.

  2. December 27, 2010

    Product Liability Cases To Watch In 2011

    While product liability lawyers will be looking to the U.S. Supreme Court in 2011 for more answers on the federal preemption question, a number of other cases, including one involving the role of punitive damages in personal injury drug claims, are likely to garner plenty of attention.

  3. August 31, 2010

    Prempro MDL Judge Nixes Plaintiffs' Expert Testimony

    The federal judge overseeing the Prempro multidistrict litigation has barred the testimony of two scientists who claimed that estrogen-only hormone replacement therapy can cause cancer, a ruling Pfizer Inc. says could threaten hundreds of suits involving EHRT drug Premarin.

  4. May 17, 2010

    115 Calif. Suits Cut From Prempro MDL

    A federal judge has cut 115 cases from the multidistrict litigation alleging Wyeth Pharmaceuticals Inc.'s hormone replacement pill Prempro caused breast cancer, ruling that the cases are barred by California's two-year statute of limitations.

  5. July 27, 2009

    Wyeth's 'Medical Ghostwriting' Docs To See Daylight

    The judge in charge of the multidistrict litigation over Wyeth Pharmaceuticals Inc.'s drug Prempro has unsealed discovery pertaining to "medical ghostwriting," granting a bid from a medical journal seeking to expose drugmakers that pay for journal articles.

  6. July 02, 2009

    Wyeth Wins Sanctions Against Firm In Prempro MDL

    A judge in charge of the multidistrict litigation over Wyeth Pharmaceuticals Inc.'s hormone replacement pill Prempro has followed through on his threat to sanction Bailey & Galyen, a law firm representing hundreds of plaintiffs, for its failure to timely produce completed client fact sheets.

  7. March 02, 2009

    Judge Threatens To Sanction Firm In Prempro MDL

    A judge has ordered a law firm representing hundreds of plaintiffs in multidistrict litigation over Wyeth Pharmaceuticals Inc.'s hormone replacement pill Prempro to produce completed fact sheets for each of its clients within 45 days or risk dismissal and sanctions from the court.

  8. January 28, 2009

    Judge Sets Deadline For Prempro MDL Discovery

    The judge presiding over a slew of cases alleging that Prempro and related hormone-replacement drugs cause breast cancer has ordered the plaintiffs to end their drawn-out discovery involving defendants Pfizer Inc. and Wyeth Pharmaceuticals Inc. by Sept. 1.

  9. January 20, 2009

    Medical Groups Dismissed From Prempro MDL

    Three medical organizations have been dismissed from a slew of lawsuits brought over the advertisement and sale of hormone treatments that allegedly cause breast cancer.

  10. January 16, 2009

    Judge Slams 'Boilerplate' Prempro Claims

    A federal judge has issued a stinging rebuke over the “generic” nature of one complaint in the massive multidistrict litigation over Prempro and related hormone-replacement drugs, saying the plaintiffs' failure to provide specific details is representative of the “boilerplate language” of other claims that have been filed against Wyeth Pharmaceuticals Inc., Bristol-Myers Squibb Co., Pfizer Inc. and other drugmakers.